{"product_id":"ucla-heart-failure-symposium-2023","title":"UCLA Heart Failure Symposium 2023","description":"\u003cstrong\u003eFormat : 18 videos + 1 pdf, size: 5.1 GB\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eUCLA Heart Failure Symposium 2023 Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease.\u003cbr\u003e\u003cbr\u003eAcademic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients.\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch4\u003eThe 11th Annual UCLA Heart Failure Symposium 2023 will:\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eDiscuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.\u003c\/li\u003e\n\u003cli\u003eEmphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.\u003c\/li\u003e\n\u003cli\u003eDiscuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cstrong\u003eTARGET AUDEINCE\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eFamily practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLEARNING OBJECTIVES\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAt the conclusion of the program participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population.\u003c\/li\u003e\n\u003cli\u003eIdentify indications for and management of lifelong left ventricular assist device therapy.\u003c\/li\u003e\n\u003cli\u003eImplement shared care programs with the community and co-manage patients in need of complex cardiac therapies including LVAD therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous interventions, and complex congenital heart disease management.\u003c\/li\u003e\n\u003cli\u003eDiscuss the comprehensive multidisciplinary care and services available to complex cardiac patients within the UCLA Heart Failure Program.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eheart_failure_2023h.pdf\u003c\/li\u003e\n\u003cli\u003eA New Era of Organ Preservation and Procurement in Heart Transplantation Going the Distance.mp4\u003c\/li\u003e\n\u003cli\u003eA Road to Recovery Cardiac Rehabilitation in CardiomyopathyA Road to Recovery Cardiac Rehabilitation in Cardiomyopathy.mp4\u003c\/li\u003e\n\u003cli\u003eAdult Congenital Heart Disease Novel Therapeutics and Interventions.mp4\u003c\/li\u003e\n\u003cli\u003eAortic Stenosis in Heart Failure Patients When to Consider TAVR .mp4\u003c\/li\u003e\n\u003cli\u003eBreakthroughs in Heart Failure Therapies and Digital Health A Look at What the Future Holds.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Amyloidosis A New Era of diagnostics and Therapeutics.mp4\u003c\/li\u003e\n\u003cli\u003eCardio-obstetrics Maternal Health in Cardiomyopathy Patients.mp4\u003c\/li\u003e\n\u003cli\u003eCardio-Oncology The Interplay of Immunotherapy, Inflammation, and Cardiomyopathy.mp4\u003c\/li\u003e\n\u003cli\u003eGenetic Testing for Cardiomyopathy.mp4\u003c\/li\u003e\n\u003cli\u003eInterventions to Time to Relax- Novel Therapies for Hypertrophic Cardiomyopathy.mp4\u003c\/li\u003e\n\u003cli\u003ePulmonary Hypertension Management From Surgical to Medical Therapies.mp4\u003c\/li\u003e\n\u003cli\u003eState of the Art Debate High Risk PCI vs High Risk CABG in Heart Failure PatientsState of the Art Debate High Risk PCI vs High Risk CABG in Heart Failure Patients.mp4\u003c\/li\u003e\n\u003cli\u003eState of the Art Medical Therapies in Advanced Heart Failure What is New in 2023.mp4\u003c\/li\u003e\n\u003cli\u003eState of the Art Therapies Mitral Valve Clip \u0026amp; Minimally Invasive Surgery for Mitral Regurgitation 1.mp4\u003c\/li\u003e\n\u003cli\u003eState of the Art Therapies Mitral Valve Clip \u0026amp; Minimally Invasive Surgery for Mitral Regurgitation 2.mp4\u003c\/li\u003e\n\u003cli\u003eTemporary Percutaneous Support, Durable MCS, and Shared care in the Community.mp4\u003c\/li\u003e\n\u003cli\u003eUCLA Mobile ECMO Updates Managing Shock in the Community.mp4\u003c\/li\u003e\n\u003cli\u003eWorking in Sync Device Therapy and Arrhythmia Management.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954420781154,"sku":"MED-AMB03208","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCLA-Heart-Failure-Symposium-2023.jpg?v=1779376097","url":"https:\/\/meducourse.com\/products\/ucla-heart-failure-symposium-2023","provider":"Meducourse","version":"1.0","type":"link"}